- Research Report University Hospital of the clinical trial CC-5013-MCL-002Publication without faculty affiliation
- Lenalidomid (Revlimid) in the Treatment of Multiple Myeloma – First Experience in the Czech Republic2008 | First Faculty of Medicine
- Lenalidomid (Revlimid) in the Treatment of Multiple Myeloma – First Experience in the Czech Republic2008 | Publication without faculty affiliation
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. CC-5013-CLL-008Publication without faculty affiliation
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. CC-5013-DLC-001Publication without faculty affiliation
- Zpráva z posledních analýz terapie Vidazou (azacitidin) a Revlimidem (lenalidomid) nemocných s myelodysplastickým syndromem v ČR - data z MyDyS registru2019 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové